BioCentury
ARTICLE | Company News

Vectura, Novartis deal

April 27, 2009 7:00 AM UTC

Vectura received a €2.5 million ($3.3 million) milestone payment from Novartis under a 2006 deal granting Novartis' Sandoz International GmbH generics unit European rights to develop and commercialize...